Sasol Shares Face Downgrade-Driven Selloff
17.01.2026 - 08:04:05Shares of the South African energy and chemicals group Sasol Ltd. came under significant pressure in Friday's trading session. The stock's decline was pronounced on both its primary listings, setting a negative tone driven by a major investment bank's revised assessment.
On the Johannesburg Stock Exchange (JSE), Sasol's equity closed approximately 12% lower. The selloff was even more severe on the New York Stock Exchange (NYSE), where American Depositary Receipts (ADRs) plunged 14.5%. The NYSE session concluded with the share price at $6.1050, down from a previous close of $7.15. This heightened activity was reflected in trading volume, which surged by 96% on the NYSE compared to the prior session.
Catalyst: JPMorgan's Revised Rating
The primary catalyst for the sharp decline was a rating downgrade from analysts at JPMorgan. The bank shifted its stance on Sasol from "Neutral" to "Underweight," simultaneously reducing its price target for the JSE-listed shares from 107 South African Rand to ZAR 94. In their rationale, JPMorgan pointed to a reassessment of key risks facing the company. These include expectations for weaker oil prices once current geopolitical tensions ease and the potential for a strengthening South African Rand, both seen as headwinds for Sasol's future earnings.
This downgrade abruptly reversed a brief mid-week rally. Shares had initially benefited from a spike in crude oil prices, but gains evaporated as oil retreated and the associated geopolitical risk premium diminished.
Should investors sell immediately? Or is it worth buying Sasol?
Operational Performance Context
The market's reaction stands in contrast to the company's recent operational update. On October 23, 2025, Sasol released a Business Performance Metrics report for the first quarter of its 2026 fiscal year (Q1 FY26). The company reported "solid progress," highlighting improved operational metrics, increased production volumes within its South African value chain, and growing revenue from its international chemicals business.
Despite these positive operational developments, broader macroeconomic concerns and the analyst downgrade dominated investor sentiment. It is worth noting that other financial institutions have also expressed caution over the past year. Morgan Stanley downgraded the stock to "Equal Weight," while Zacks Investment Research moved its rating to "Strong Sell."
Technical and Fundamental Outlook
From a technical perspective, the share price on the JSE is testing crucial support levels around the R100 mark. The near-term trajectory may depend on its ability to hold above this level, coupled with stabilization in oil prices and currency exchange rates. A sustained break below this support could invite further selling pressure.
The next significant milestone for investors will be the company's scheduled financial results announcement on March 2, 2026. This update is anticipated to provide fresh directional cues. Based on the limited number of current analyst estimates, the average price target for Sasol's NYSE-listed ADRs sits at $6.81.
Ad
Sasol Stock: Buy or Sell?! New Sasol Analysis from January 17 delivers the answer:
The latest Sasol figures speak for themselves: Urgent action needed for Sasol investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 17.
Sasol: Buy or sell? Read more here...


